(Q54954411)

English

SK-N-AS

cell line

SKN-AS
SKNAS

In more languages

Statements

1 reference

Cellosaurus release 44

31 January 2023

cancer cell line

1 reference

Cellosaurus release 44

31 January 2023

described by source

Human neuroblastoma cells and 13-cis-retinoic acid.

1 reference

Cellosaurus release 44

31 January 2023

Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification.

1 reference

Cellosaurus release 44

31 January 2023

Comparative genomic hybridization analysis of human neuroblastomas: detection of distal 1p deletions and further molecular genetic characterization of neuroblastoma cell lines.

1 reference

Cellosaurus release 44

31 January 2023

Combined M-FISH and CGH analysis allows comprehensive description of genetic alterations in neuroblastoma cell lines

1 reference

Cellosaurus release 44

31 January 2023

PPM1D is a potential target for 17q gain in neuroblastoma

1 reference

Cellosaurus release 44

31 January 2023

Mutations in PIK3CA are infrequent in neuroblastoma

1 reference

Cellosaurus release 44

31 January 2023

Identification of ALK as a major familial neuroblastoma predisposition gene

1 reference

Cellosaurus release 44

31 January 2023

A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers

1 reference

Cellosaurus release 44

31 January 2023

PEA15 impairs cell migration and correlates with clinical features predicting good prognosis in neuroblastoma

1 reference

Cellosaurus release 44

31 January 2023

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

1 reference

Cellosaurus release 44

31 January 2023

Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma

1 reference

Cellosaurus release 44

31 January 2023

Testing of SNS-032 in a Panel of Human Neuroblastoma Cell Lines with Acquired Resistance to a Broad Range of Drugs

1 reference

Cellosaurus release 44

31 January 2023

A comprehensive transcriptional portrait of human cancer cell lines

1 reference

Cellosaurus release 44

31 January 2023

A landscape of pharmacogenomic interactions in cancer.

1 reference

Cellosaurus release 44

31 January 2023

Acquired resistance to oxaliplatin is not directly associated with increased resistance to DNA damage in SK-N-ASrOXALI4000, a newly established oxaliplatin-resistant sub-line of the neuroblastoma cell line SK-N-AS

1 reference

Cellosaurus release 44

31 January 2023

Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines.

1 reference

Cellosaurus release 44

31 January 2023

Mutations of the BRAF gene in human cancer

1 reference

Cellosaurus release 44

31 January 2023

Effect of bortezomib on human neuroblastoma: analysis of molecular mechanisms involved in cytotoxicity

1 reference

Cellosaurus release 44

31 January 2023

Signatures of mutation and selection in the cancer genome

1 reference

Cellosaurus release 44

31 January 2023

An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines

1 reference

Cellosaurus release 44

31 January 2023

Next-generation characterization of the Cancer Cell Line Encyclopedia

1 reference

Cellosaurus release 44

31 January 2023

Quantitative Proteomics of the Cancer Cell Line Encyclopedia.

1 reference

Cellosaurus release 44

31 January 2023

Determination of cell surface membrane antigens common to both human neuroblastoma and leukemia-lymphoma cell lines by a panel of 38 monoclonal antibodies.

1 reference

Cellosaurus release 44

31 January 2023

High-resolution detection and mapping of genomic DNA alterations in neuroblastoma

1 reference

Cellosaurus release 44

31 January 2023

NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome

1 reference

Cellosaurus release 44

31 January 2023

1H MRS identifies specific metabolite profiles associated with MYCN-amplified and non-amplified tumour subtypes of neuroblastoma cell lines

1 reference

Cellosaurus release 44

31 January 2023

Phosphoproteome and gene expression profiling of ALK inhibition in neuroblastoma cell lines reveals conserved oncogenic pathways

1 reference

Cellosaurus release 44

31 January 2023

established from medical condition

1 reference

Cellosaurus release 44

31 January 2023

derived from organism type

1 reference

Cellosaurus release 44

31 January 2023

http://purl.obolibrary.org/obo/BTO_0002827

1 reference

Cellosaurus release 44

31 January 2023

http://purl.obolibrary.org/obo/EFO_0002859

1 reference

Cellosaurus release 44

31 January 2023

http://purl.obolibrary.org/obo/CLO_0009051

1 reference

Cellosaurus release 44

31 January 2023

Identifiers

Cell Line Ontology ID

1 reference

Cellosaurus release 44

31 January 2023

1 reference

Cellosaurus release 44

31 January 2023

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54954411&oldid=1861743233"